|
MCM9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20540000003722E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.61860000000336E-05 |
| Normal-vs-Stage2 |
6.32299999999697E-05 |
| Normal-vs-Stage3 |
4.72900000270116E-08 |
| Normal-vs-Stage4 |
3.026800E-04 |
| Stage1-vs-Stage2 |
3.136800E-01 |
| Stage1-vs-Stage3 |
2.188200E-02 |
| Stage1-vs-Stage4 |
2.913800E-01 |
| Stage2-vs-Stage3 |
5.175800E-01 |
| Stage2-vs-Stage4 |
9.640200E-01 |
| Stage3-vs-Stage4 |
6.108600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.52139999948831E-07 |
| Normal-vs-AfricanAmerican |
4.397800E-03 |
| Normal-vs-Asian |
1.411910E-02 |
| Caucasian-vs-AfricanAmerican |
7.746800E-01 |
| Caucasian-vs-Asian |
1.205180E-01 |
| AfricanAmerican-vs-Asian |
4.556400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.793230E-04 |
| Normal-vs-Female |
6.46089999944977E-07 |
| Male-vs-Female |
4.928800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.043500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.48520000001307E-06 |
| Normal-vs-Age(61-80Yrs) |
1.66611999999899E-05 |
| Normal-vs-Age(81-100Yrs) |
2.435800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.524000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.025970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.379800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.376200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.680300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.818000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.6607999999696E-06 |
| Classical-VS-Follicular |
9.944200E-01 |
| Classical-VS-Other |
6.025200E-01 |
| Classical-VS-Normal |
3.92610000000682E-05 |
| Tall-VS-Follicular |
2.427200E-04 |
| Tall-VS-Other |
4.850100E-02 |
| Tall-VS-Normal |
4.64129845667571E-11 |
| Follicular-VS-Other |
6.521000E-01 |
| Follicular-VS-Normal |
1.079260E-03 |
| Other-VS-Normal |
2.338000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14310000001827E-06 |
| Normal-vs-N1 |
2.554500E-02 |
| N0-vs-N1 |
2.813600E-01 |
|
|
